Literature DB >> 2750791

A case-control study of epithelial ovarian cancer.

P Hartge1, M H Schiffman, R Hoover, L McGowan, L Lesher, H J Norris.   

Abstract

With data from a study of 296 patients with primary epithelial ovarian cancer and 343 patients hospitalized because of other conditions, we estimated ovarian cancer risk in accordance with reproductive and other factors. Risk was greatest among women of lower parity, especially among women who said they planned to have children but could not. The protective effect of oral contraceptives seen in other studies was observed only in subgroups of our study population. Women who had breastfed their children had decreased risk, but the number of months of breastfeeding was not related to risk. Incomplete pregnancies did not provide the protection seen for live births. A family history of ovarian cancer and a medical history of breast cancer were both strong risk factors. None of the nonreproductive factors that we examined, including childhood illnesses, tobacco and alcohol consumption, obesity, and selected adult diseases, was convincingly associated with risk.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2750791     DOI: 10.1016/0002-9378(89)90221-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.

Authors:  Nan-Nan Luan; Qi-Jun Wu; Ting-Ting Gong; Emily Vogtmann; Yong-Lai Wang; Bei Lin
Journal:  Am J Clin Nutr       Date:  2013-08-21       Impact factor: 7.045

2.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

Review 3.  Oral contraceptives and cancer: an update.

Authors:  C La Vecchia; A Altieri; S Franceschi; A Tavani
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Pharmacoeconomic considerations in treating ovarian cancer.

Authors:  D Bodurka-Bevers; C C Sun; D M Gershenson
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

Review 5.  Hereditary ovarian cancer in Ashkenazi Jews.

Authors:  Luis Robles-Díaz; Deborah J Goldfrank; Noah D Kauff; Mark Robson; Kenneth Offit
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  Coffee and caffeine intake and the risk of ovarian cancer: the Iowa Women's Health Study.

Authors:  Natalie A Lueth; Kristin E Anderson; Lisa J Harnack; Jayne A Fulkerson; Kim Robien
Journal:  Cancer Causes Control       Date:  2008-08-14       Impact factor: 2.506

7.  Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.

Authors:  Albert Asante; Phoebe H Leonard; Amy L Weaver; Ellen L Goode; Jani R Jensen; Elizabeth A Stewart; Charles C Coddington
Journal:  Fertil Steril       Date:  2013-04-01       Impact factor: 7.329

8.  Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.

Authors:  I B Runnebaum; X W Tong; V Moebus; V Heilmann; D G Kieback; R Kreienberg
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

9.  Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.

Authors: 
Journal:  PLoS Med       Date:  2012-04-03       Impact factor: 11.069

10.  Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan.

Authors:  Cherry Yin-Yi Chang; Kent Yu-Hsien Lin; Chien-Chu Huang; Wu-Chou Lin
Journal:  BMC Womens Health       Date:  2021-07-28       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.